In Stock
CJC-1295+IPAMORELIN
CJC-1295 with Ipamorelin for GH-axis secretagogue research. Complementary GHRH and ghrelin-receptor mechanisms for laboratory study.
$109.00
$89.00/ item
š¬ Volume Savings
3 VialsSave 10%
5 VialsSave 15%
10 VialsSave 20% ā Best Value
Quantity
1
Total Price
$89.00š 2 Day Express ā $15 | Add $199.00 for FREE Shipping
For laboratory and research purposes only. Not for human or animal consumption. No medical claims are made.
Compound Information
CJC-1295 and Ipamorelin are two distinct peptides frequently studied together in research settings due to their complementary mechanisms involving growth hormone release pathways. CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue. Researchers commonly investigate this combination for its synergistic effects on GH pulse amplitude and frequency in preclinical models.
CJC-1295 binds to GHRH receptors on pituitary somatotroph cells, stimulating the release of growth hormone. Its DAC modification extends its half-life significantly compared to native GHRH. Ipamorelin acts on ghrelin receptors (GHS-R1a) and is noted in studies for its selectivity ā it does not significantly stimulate cortisol, prolactin, or ACTH release at research doses. Published research has examined this pairing in preclinical models investigating GH-axis signaling, body-composition endpoints, and recovery-physiology endpoints.
Vial Size: 10mg
CJC-1295 ā CAS Number: 446262-90-4, Molecular Formula: C165H269N47O46 | Ipamorelin ā CAS Number: 170851-70-4, Molecular Formula: C38H49N9O5 | Purity: See published COA where available | Storage: Lyophilized powder; store at -20Ā°C.
